US Could Face Vax Shortages Amid Global Competition

Politico reports:

The United States could be heading for a vaccine cliff this spring, with shortages forcing hundreds of millions of Americans to wait for shots amid intense global competition for limited doses.

The Trump administration has bought 100 million doses each of vaccines from Pfizer and Moderna, but the U.S. is unlikely to get additional doses anytime soon because of strong international demand.

Reports this week that the U.S. government turned down opportunities to buy up to 400 million more Pfizer shots have raised fresh questions about how the country will secure its supply.

Read the full article.